131 related articles for article (PubMed ID: 31404748)
1. Generation of two H1 hESC sublines carrying deletions of RB1 exon 1/promoter in heterozygous or compound heterozygous state.
Menges J; Cremanns M; Steenpass L
Stem Cell Res; 2019 Aug; 39():101517. PubMed ID: 31404748
[TBL] [Abstract][Full Text] [Related]
2. Biallelic and monoallelic deletion of the RB1 promoter in six isogenic clonal H9 hESC lines.
Döpper H; Horstmann M; Menges J; Bozet M; Kanber D; Steenpass L
Stem Cell Res; 2020 May; 45():101779. PubMed ID: 32268247
[TBL] [Abstract][Full Text] [Related]
3. Generation of two H1 hESC sublines carrying a heterozygous and homozygous knock-out of RB1.
Steenpass L
Stem Cell Res; 2017 Dec; 25():270-273. PubMed ID: 29246572
[TBL] [Abstract][Full Text] [Related]
4. Generation and characterization of three CRISPR/Cas9 edited RB1 null hiPSC lines for retinoblastoma disease modelling.
Agrawal T; Maddileti S; Mariappan I
Stem Cell Res; 2024 Apr; 76():103373. PubMed ID: 38452707
[TBL] [Abstract][Full Text] [Related]
5. Spectrum of mutations in the
Kiet NC; Khuong LT; Minh DD; ; Quan NHM; Xinh PT; Trang NNC; Luan NT; Khai NM; Vu HA
Mol Vis; 2019; 25():215-221. PubMed ID: 30996590
[TBL] [Abstract][Full Text] [Related]
6. Generation of heterozygous and homozygous hESC H9 sublines carrying inactivating mutations in RB1.
Schipper L; Kanber D; Steenpass L
Stem Cell Res; 2018 Dec; 33():41-45. PubMed ID: 30312872
[TBL] [Abstract][Full Text] [Related]
7. Characterization of human-induced pluripotent stem cells carrying homozygous RB1 gene deletion.
Deng X; Iwagawa T; Fukushima M; Watanabe S
Genes Cells; 2020 Jul; 25(7):510-517. PubMed ID: 32277725
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of germline
Rojanaporn D; Boontawon T; Chareonsirisuthigul T; Thanapanpanich O; Attaseth T; Saengwimol D; Anurathapan U; Sujirakul T; Kaewkhaw R; Hongeng S
Mol Vis; 2018; 24():778-788. PubMed ID: 30636860
[TBL] [Abstract][Full Text] [Related]
9. Generation of human embryonic stem cell line with heterozygous RB1 deletion by CRIPSR/Cas9 nickase.
Tu J; Huo Z; Liu M; Wang D; Xu A; Zhou R; Zhu D; Gingold J; Shen J; Zhao R; Lee DF
Stem Cell Res; 2018 Apr; 28():29-32. PubMed ID: 29414415
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9 mediated knockout of rb1 and rbl1 leads to rapid and penetrant retinoblastoma development in Xenopus tropicalis.
Naert T; Colpaert R; Van Nieuwenhuysen T; Dimitrakopoulou D; Leoen J; Haustraete J; Boel A; Steyaert W; Lepez T; Deforce D; Willaert A; Creytens D; Vleminckx K
Sci Rep; 2016 Oct; 6():35264. PubMed ID: 27739525
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the methylation changes in the promoter region of RB1 gene in retinoblastoma: Unraveling the epigenetic puzzle in retinoblastoma.
Erdoğan ÖŞ; Ödemiş DA; Kayım ZY; Gürbüz O; Tunçer ŞB; Kılıç S; Çelik B; Tuncer S; Bay SB; Kebudi R; Yazıcı H
Pathol Res Pract; 2024 Jan; 253():154939. PubMed ID: 38006838
[TBL] [Abstract][Full Text] [Related]
12. "Monoallelic germline methylation and sequence variant in the promoter of the RB1 gene: a possible constitutive epimutation in hereditary retinoblastoma".
Quiñonez-Silva G; Dávalos-Salas M; Recillas-Targa F; Ostrosky-Wegman P; Aranda DA; Benítez-Bribiesca L
Clin Epigenetics; 2016; 8():1. PubMed ID: 26753011
[TBL] [Abstract][Full Text] [Related]
13. Detection and reporting of RB1 promoter hypermethylation in diagnostic screening.
Price EA; Kolkiewicz K; Patel R; Hashim S; Karaa E; Scheimberg I; Sagoo MS; Reddy MA; Onadim Z
Ophthalmic Genet; 2018 Aug; 39(4):526-531. PubMed ID: 29851531
[TBL] [Abstract][Full Text] [Related]
14. RB1 gene mutations and genetic spectrum in retinoblastoma cases.
Akdeniz Odemis D; Kebudi R; Bayramova J; Kilic Erciyas S; Kuru Turkcan G; Tuncer SB; Sukruoglu Erdogan O; Celik B; Kurt Gultaslar B; Buyukkapu Bay S; Tuncer S; Yazici H
Medicine (Baltimore); 2023 Sep; 102(36):e35068. PubMed ID: 37682130
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of human retinoblastoma.
Singh U; Malik MA; Goswami S; Shukla S; Kaur J
Tumour Biol; 2016 Nov; 37(11):14427-14441. PubMed ID: 27639385
[TBL] [Abstract][Full Text] [Related]
16. Evidence of predisposing epimutation in retinoblastoma.
Gelli E; Pinto AM; Somma S; Imperatore V; Cannone MG; Hadjistilianou T; De Francesco S; Galimberti D; Currò A; Bruttini M; Mari F; Renieri A; Ariani F
Hum Mutat; 2019 Feb; 40(2):201-206. PubMed ID: 30427563
[TBL] [Abstract][Full Text] [Related]
17. The
Berry JL; Polski A; Cavenee WK; Dryja TP; Murphree AL; Gallie BL
Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31683923
[TBL] [Abstract][Full Text] [Related]
18. Generation of induced pluripotent stem cells (iPSCs) from a retinoblastoma patient carrying a c.2663G>A mutation in RB1 gene.
Zeng S; Liu L; Ouyang Q; Zhao Y; Lin G; Hu L; Li W
Stem Cell Res; 2016 Sep; 17(2):208-211. PubMed ID: 27879208
[TBL] [Abstract][Full Text] [Related]
19. Generation of an induced pluripotent stem cell line (LVPEIi002-A) with heterozygous RB1 mutation using peri-orbital fat derived mesenchymal cells of a patient with inherited retinoblastoma.
Agrawal T; Maddileti S; Verma A; Kaliki S; Mariappan I
Stem Cell Res; 2024 Apr; 76():103329. PubMed ID: 38335663
[TBL] [Abstract][Full Text] [Related]
20. Impact of RB1 gene mutation type in retinoblastoma patients on clinical presentation and management outcome.
Mehyar M; Mosallam M; Tbakhi A; Saab A; Sultan I; Deebajah R; Jaradat I; AlJabari R; Mohammad M; AlNawaiseh I; Al-Hussaini M; Yousef YA
Hematol Oncol Stem Cell Ther; 2020 Sep; 13(3):152-159. PubMed ID: 32222358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
